Read + Share
Walter S, Ho J, Alvarado R, Smith G, et al. Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in
eosinophilic chronic rhinosinusitis. Clin Exp Allergy 2022;52:1403-1413.
PMID: 35475305
|
 |
|
Walter S, Ho J, Alvarado R, Smith G, et al. Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in
eosinophilic chronic rhinosinusitis. Clin Exp Allergy 2022;52:1403-1413.
PMID: 35475305
|
|
|
|